Page last updated: 2024-08-17

n,n-dimethyltryptamine and Depressive Disorder, Treatment-Resistant

n,n-dimethyltryptamine has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tullis, P1

Other Studies

1 other study(ies) available for n,n-dimethyltryptamine and Depressive Disorder, Treatment-Resistant

ArticleYear
How ecstasy and psilocybin are shaking up psychiatry.
    Nature, 2021, Volume: 589, Issue:7843

    Topics: Animals; Certification; Clinical Trials as Topic; Depression; Depressive Disorder, Treatment-Resistant; Drug Prescriptions; Efficiency; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; N,N-Dimethyltryptamine; Neuronal Plasticity; Niacin; Psilocybin; Psychiatry; Psychotherapy; Rumination, Cognitive; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress Disorders, Post-Traumatic

2021